Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours
Condition(s):Testicular NeoplasmsLast Updated:October 19, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Testicular NeoplasmsLast Updated:October 19, 2020Completed
Condition(s):Breast Cancer; Colorectal Cancer; Lymphoma; Prostate Cancer; Testicle CancerLast Updated:February 29, 2024Completed
Condition(s):Lung CancerLast Updated:March 19, 2020Completed
Condition(s):Testicular Neoplasms; Germ Cell TumorsLast Updated:June 12, 2014Completed
Condition(s):Ovarian Dysgerminoma; Recurrent Malignant Testicular Germ Cell Tumor; Recurrent Ovarian Germ Cell Tumor; Stage II Malignant Testicular Germ Cell Tumor; Stage II Ovarian Germ Cell Tumor; Stage III Malignant Testicular Germ Cell Tumor; Stage III Ovarian Germ Cell Tumor; Testicular SeminomaLast Updated:January 17, 2013Terminated
Condition(s):Lymphoma; Breast Cancer; Testicular Cancer; SarcomaLast Updated:January 5, 2024Not yet recruiting
Condition(s):Germ Cell CancerLast Updated:November 21, 2023Completed
Condition(s):Non Small Cell Lung CancerLast Updated:June 11, 2020Unknown status
Condition(s):Acute Myelogenous LeukemiaLast Updated:May 9, 2017Withdrawn
Condition(s):Testicular Cancer; Leukemia; Lymphoma; Brain CancerLast Updated:April 20, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.